ACE2 and COVID-19: As shown in the Figures 1A, B, the levels of ACE2 and AXL in the COVID-19 group were significantly lower than in the non-infected group, while SARS-COV-2 IgG was significantly higher in the COVID-19 group (Figure 1C).